Cefuroxime data
Response to an Official Information Act request for data on cefuroxime.
21 November 2019
[name and contact details redacted]
Dear [name redacted]
REQUEST FOR INFORMATION
Thank you for your request dated 24 October 2019 under the Official Information Act 1982 (OIA). You asked for
the last three year sales of Cefuroxine 1.5G and 750mg injections especially in relation to hospital and retail pharmacy use.
We have interpreted your reference to ‘Cefuroxine’ as meaning ‘Cefuroxime’.
In respect of sales for Cefuroxime for retail pharmacy use, these are publicly available and therefore this part of your request is declined under section 18(d) of the OIA. This information can be found via the Ministry of Health’s data portal(external link). To use the tool, click on the ‘data’ tab in the topline menu, then use the ‘search’ window to insert your search term.
Data on hospital use is provided below. This data is from hospital purchasing data and is for financial year to June 2019. Dollar amounts have been calculated from units dispensed, combined with subsidy values published in the NZ Pharmaceutical Schedule.
Cefuroxime – hospital use
|
Cefuroxime Sales |
Cefuroxime Units |
|||
|
Year |
Inj 1.5 g vial |
Inj 750 mg vial |
Inj 1.5 g vial |
Inj 750 mg vial |
|
2017 |
$158,263 |
$380,456 |
122,171 |
417,000 |
|
2018 |
$204,365 |
$351,712 |
147,727 |
317,715 |
|
2019 |
$228,741 |
$233,888 |
159,290 |
237,450 |
Please note you have the right, by way of complaint under section 28(3) of the OIA to an Ombudsman, to seek an investigation and review of our decision.
We trust that this information answers your queries. We are making our information more freely available, so we will now publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this.
Yours sincerely
Alison Hill
Director, Engagement and Implementation